Skip to content

A Prospective, Multicenter, Single Blind, Randomized, Controlled Trial Comparing the Lutonix Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Below-the-Knee (BTK) Arteries in Patients Undergoing Hemodialysis

A Prospective, Multicenter, Single Blind, Randomized, Controlled Trial Comparing the Lutonix Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Below-the-Knee (BTK) Arteries in Patients Undergoing Hemodialysis - Lutonix BTK - HD Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000014673
Enrollment
72
Registered
2014-07-29
Start date
2014-07-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Symptomatic occlusive disease of the peripheral arteries

Interventions

Sponsors

Medicon Inc.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Male or non-pregnant, non-breastfeeding female >=20 but <80 years of age; 2. Rutherford Clinical Category 4-5; 3. Life expectancy >=1 year; 4. Patient has been receiving chronic hemodialysis treatments (>=3 times per week) for End Stage Renal Disease (ESRD) for >=3 months (NOTE: Peritoneal dialysis treatments are not allowed); 5. Significant stenosis (>=70%) or occlusion of native artery(s) above the tibiotalar joint; etc.

Exclusion criteria

Exclusion criteria: 1. History of stroke within 3 months; 2. History of MI, thrombolysis or angina within 30 days of enrollment; 3. Prior or planned major amputation (of either leg); etc.

Design outcomes

Primary

MeasureTime frame
- Freedom from BTK MALE+POD at 30-Days - Composite of limb salvage and primary patency at 6 months

Secondary

MeasureTime frame
Primary patency, Hemodynamic outcome, Clinically-driven TLR, and wound healing

Countries

Japan

Contacts

Public ContactSoji Iida

Medicon Inc. Clinical Development

Soji.Iida@bd.com06-6203-6567

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026